- Home
- CTSO vs WGRX Comparison
CTSO vs WGRX Comparison
Compare CTSO & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- WGRX
- Stock Information
- Founded
- CTSO 1997
- WGRX 2022
- Country
- CTSO United States
- WGRX United States
- Employees
- CTSO N/A
- WGRX N/A
- Industry
- CTSO Medical/Dental Instruments
- WGRX Other Pharmaceuticals
- Sector
- CTSO Health Care
- WGRX Health Care
- Exchange
- CTSO Nasdaq
- WGRX Nasdaq
- Market Cap
- CTSO 65.7M
- WGRX 66.1M
- IPO Year
- CTSO N/A
- WGRX 2025
- Fundamental
- Price
- CTSO $0.95
- WGRX $0.87
- Analyst Decision
- CTSO Buy
- WGRX
- Analyst Count
- CTSO 2
- WGRX 0
- Target Price
- CTSO $5.50
- WGRX N/A
- AVG Volume (30 Days)
- CTSO 93.3K
- WGRX 2.3M
- Earning Date
- CTSO 08-07-2025
- WGRX 08-11-2025
- Dividend Yield
- CTSO N/A
- WGRX N/A
- EPS Growth
- CTSO N/A
- WGRX N/A
- EPS
- CTSO N/A
- WGRX N/A
- Revenue
- CTSO $35,332,238.00
- WGRX $28,992,274.00
- Revenue This Year
- CTSO $11.15
- WGRX N/A
- Revenue Next Year
- CTSO $21.39
- WGRX N/A
- P/E Ratio
- CTSO N/A
- WGRX N/A
- Revenue Growth
- CTSO 15.37
- WGRX N/A
- 52 Week Low
- CTSO $0.71
- WGRX $0.75
- 52 Week High
- CTSO $1.61
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- CTSO 39.94
- WGRX N/A
- Support Level
- CTSO $0.91
- WGRX N/A
- Resistance Level
- CTSO $1.06
- WGRX N/A
- Average True Range (ATR)
- CTSO 0.06
- WGRX 0.00
- MACD
- CTSO -0.01
- WGRX 0.00
- Stochastic Oscillator
- CTSO 13.97
- WGRX 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.